Trial Outcomes & Findings for The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults (NCT NCT04074941)
NCT ID: NCT04074941
Last Updated: 2021-05-11
Results Overview
Average of three seated systolic and diastolic blood pressure readings
COMPLETED
NA
20 participants
2 weeks
2021-05-11
Participant Flow
Of the approximately 285 residents of Jack Satter House, 59 adults expressed interest in participation. We ultimately enrolled 20 participants.
Participant milestones
| Measure |
Low Sodium Diet
This group will get a low sodium diet (\<0.9 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Usual Sodium Diet
This group will get a usual sodium diet (\~2 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
|---|---|---|
|
Overall Study
STARTED
|
11
|
9
|
|
Overall Study
COMPLETED
|
11
|
9
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults
Baseline characteristics by cohort
| Measure |
Low Sodium Diet
n=11 Participants
This group will get a low sodium diet (\<0.9 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Usual Sodium Diet
n=9 Participants
This group will get a usual sodium diet (\~2 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
76.9 years
STANDARD_DEVIATION 6.1 • n=5 Participants
|
79.6 years
STANDARD_DEVIATION 9.4 • n=7 Participants
|
78.1 years
STANDARD_DEVIATION 7.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Systolic blood pressure, mmHg
|
123.5 mmHg
STANDARD_DEVIATION 9.7 • n=5 Participants
|
121.1 mmHg
STANDARD_DEVIATION 12.2 • n=7 Participants
|
122.5 mmHg
STANDARD_DEVIATION 10.7 • n=5 Participants
|
|
Diastolic blood pressure, mmHg
|
65.3 mmHg
STANDARD_DEVIATION 11.1 • n=5 Participants
|
62 mmHg
STANDARD_DEVIATION 7.5 • n=7 Participants
|
63.9 mmHg
STANDARD_DEVIATION 9.5 • n=5 Participants
|
|
Hypertension, %
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Hypertension medication use, %
|
7 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Measured orthostatic hypertension, %
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
BMI, kg/m^2
|
32.3 kg/m^2
STANDARD_DEVIATION 7.2 • n=5 Participants
|
31.9 kg/m^2
STANDARD_DEVIATION 7.9 • n=7 Participants
|
32.1 kg/m^2
STANDARD_DEVIATION 7.3 • n=5 Participants
|
|
Montreal Cognitive Assessment score
|
24.3 scores on a scale
STANDARD_DEVIATION 3.3 • n=5 Participants
|
23.6 scores on a scale
STANDARD_DEVIATION 1.9 • n=7 Participants
|
23.9 scores on a scale
STANDARD_DEVIATION 2.7 • n=5 Participants
|
|
Physical activity score
|
15.9 scores on a scale
STANDARD_DEVIATION 15.1 • n=5 Participants
|
22.8 scores on a scale
STANDARD_DEVIATION 13.7 • n=7 Participants
|
19.0 scores on a scale
STANDARD_DEVIATION 14.5 • n=5 Participants
|
|
Timed-up-and-go, sec
|
14.0 seconds
STANDARD_DEVIATION 6.2 • n=5 Participants
|
13.4 seconds
STANDARD_DEVIATION 3.9 • n=7 Participants
|
13.7 seconds
STANDARD_DEVIATION 5.1 • n=5 Participants
|
|
Estimated calorie intake, kcal/d
|
1849 kcal/day
STANDARD_DEVIATION 244 • n=5 Participants
|
1785 kcal/day
STANDARD_DEVIATION 311 • n=7 Participants
|
1820 kcal/day
STANDARD_DEVIATION 270 • n=5 Participants
|
PRIMARY outcome
Timeframe: 2 weeksAverage of three seated systolic and diastolic blood pressure readings
Outcome measures
| Measure |
Low Sodium Diet
n=11 Participants
This group will get a low sodium diet (\<0.9 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Usual Sodium Diet
n=9 Participants
This group will get a usual sodium diet (\~2 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
|---|---|---|
|
Seated Blood Pressure
Follow-up seated systolic blood pressure
|
112.1 mmHg
Standard Deviation 7.6
|
116.1 mmHg
Standard Deviation 13.0
|
|
Seated Blood Pressure
Follow-up seated diastolic blood pressure
|
60.3 mmHg
Standard Deviation 9.6
|
60.4 mmHg
Standard Deviation 8.0
|
SECONDARY outcome
Timeframe: 2 weeksMeasured from supine and standing systolic and diastolic blood pressure readings
Outcome measures
| Measure |
Low Sodium Diet
n=11 Participants
This group will get a low sodium diet (\<0.9 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Usual Sodium Diet
n=9 Participants
This group will get a usual sodium diet (\~2 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
|---|---|---|
|
Orthostatic Hypotension
|
3 Participants
|
5 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 2 weeksParticipant will be asked to start from seated position, stand up from the chair, walk 3 meters in a straight line, turn, walk back to the chair and sit down. The investigators will use average of the two trials.
Outcome measures
| Measure |
Low Sodium Diet
n=11 Participants
This group will get a low sodium diet (\<0.9 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Usual Sodium Diet
n=9 Participants
This group will get a usual sodium diet (\~2 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
|---|---|---|
|
Timed up and go Test
|
13.8 seconds
Standard Deviation 5.6
|
13.8 seconds
Standard Deviation 4.9
|
Adverse Events
Low Sodium Diet
Usual Sodium Diet
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Low Sodium Diet
n=11 participants at risk
This group will get a low sodium diet (\<0.9 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
Usual Sodium Diet
n=9 participants at risk
This group will get a usual sodium diet (\~2 mg per kcal of energy intake).
Dietary intervention: Intervention include low sodium or usual sodium diet
|
|---|---|---|
|
Endocrine disorders
High blood glucose in participants with baseline diabetes
|
0.00%
0/11 • 2 weeks
|
22.2%
2/9 • Number of events 2 • 2 weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place